Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Proclemer

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
International Journal of Cardiology|January 5, 2013
Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] studyAlessandro Proclemer, Daniele Muser, Andrea Campana, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2009
Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III TrialJoerg O Schwab, Maurizio Gasparini, Maurizio Lunati, et al.
Circulation|May 20, 2014
Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trialAxel Kloppe, Alessandro Proclemer, Angel Arenal, et al.
JAMA|May 9, 2013
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trialMaurizio Gasparini, Alessandro Proclemer, Catherine Klersy, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2016
Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trialAngel Arenal, Alessandro Proclemer, Axel Kloppe, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2015
EHRA research network surveys: 6 years of EP wires activityMaria Grazia Bongiorni, Jian Chen, Nikolaos Dagres, et al.
The American Journal of Cardiology|September 23, 2008
Usefulness of echo-guided cardiac resynchronization pacing in patients undergoing "ablate and pace" therapy for permanent atrial fibrillation and effects of heart rate regularization and left ventricular resynchronizationMichele Brignole, Carlo Menozzi, Gian Luca Botto, et al.
Heart (British Cardiac Society)|December 13, 2019
Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection timesMaurizio Gasparini, Axel Kloppe, Maurizio Lunati, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III TrialMaurizio Gasparini, Maurizio G Lunati, Alessandro Proclemer, et al.
European Journal of Heart Failure|July 15, 2016
Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapyManlio Cipriani, Maurizio Lunati, Maurizio Landolina, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Cardiology|January 5, 2013
Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] studyAlessandro Proclemer, Daniele Muser, Andrea Campana, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2009
Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III TrialJoerg O Schwab, Maurizio Gasparini, Maurizio Lunati, et al.
Circulation|May 20, 2014
Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trialAxel Kloppe, Alessandro Proclemer, Angel Arenal, et al.
JAMA|May 9, 2013
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trialMaurizio Gasparini, Alessandro Proclemer, Catherine Klersy, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2016
Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trialAngel Arenal, Alessandro Proclemer, Axel Kloppe, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2015
EHRA research network surveys: 6 years of EP wires activityMaria Grazia Bongiorni, Jian Chen, Nikolaos Dagres, et al.
The American Journal of Cardiology|September 23, 2008
Usefulness of echo-guided cardiac resynchronization pacing in patients undergoing "ablate and pace" therapy for permanent atrial fibrillation and effects of heart rate regularization and left ventricular resynchronizationMichele Brignole, Carlo Menozzi, Gian Luca Botto, et al.
Heart (British Cardiac Society)|December 13, 2019
Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection timesMaurizio Gasparini, Axel Kloppe, Maurizio Lunati, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III TrialMaurizio Gasparini, Maurizio G Lunati, Alessandro Proclemer, et al.
European Journal of Heart Failure|July 15, 2016
Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapyManlio Cipriani, Maurizio Lunati, Maurizio Landolina, et al.
Pageof 17